1H-NMR structures of the Plasmodium falciparum 1758 erythrocyte binding peptide analogues and protection against malaria. (Q47916391)

6 February 2018

title

1H-NMR structures of the Plasmodium falciparum 1758 erythrocyte binding peptide analogues and protection against malaria. (English)

1 reference

6 February 2018

main subject

Plasmodium falciparum

0 references

0 references

1 reference

Manuel-Elkin Patarroyo

6

1 reference

6 February 2018

author name string

Fanny Guzman

1

1 reference

6 February 2018

Katherine Jaramillo

2

1 reference

6 February 2018

Luz M Salazar

3

1 reference

6 February 2018

Angela Torres

4

1 reference

6 February 2018

Augusto Rivera

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 October 2002

1 reference

6 February 2018

published in

Life Sciences

1 reference

6 February 2018

volume

71

1 reference

6 February 2018

issue

23

1 reference

6 February 2018

page(s)

2773-2785

1 reference

6 February 2018

Invasion of erythrocytes by malaria parasites: a cellular and molecular overview

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Two alleles of the 175-kilodalton Plasmodium falciparum erythrocyte binding antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Plasmodium falciparum EBA-175 kDa protein peptides which bind to human red blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Sequence and diversity of T-cell receptor beta-chain V and J genes of the owl monkey Aotus nancymaae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Sequence and diversity of DRB genes of Aotus nancymaae, a primate model for human malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Environment affects amino acid preference for secondary structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Evidence for two-stage binding by the 175-kD erythrocyte binding antigen of Plasmodium falciparum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Classification and prediction of beta-turn types.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902108-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(02)02108-2

1 reference

6 February 2018

PubMed ID

12383883

1 reference

6 February 2018